VIA
SYRE icon

Virtus Investment Advisers’s Spyre Therapeutics SYRE Stock Holding History

Virtus Investment Advisers’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$79.5K Sell
5,310
-1,551
-23% -$23.2K 0.03% 424
2025
Q1 		$111K Buy
+6,861
New +$111K 0.03% 406